Medical Necessity Determination for HIV PrEP Following Completed PEP Course

Rationale for PrEP After PEP Completion

• The Centers for Disease Control and Prevention (CDC) recommends transition from PEP to PrEP for patients with documented HIV exposure who complete a 28-day PEP course, as ongoing risk assessment may warrant continued prophylaxis 1, 2
• The CDC recommends HIV antibody testing at 6 weeks, 12 weeks, and 6 months post-exposure for all patients completing PEP 3, 4

Critical Hepatic Monitoring Requirements

• Baseline liver function tests are mandatory before initiating any tenofovir-based regimen, with repeat testing at 1 month, then quarterly monitoring due to the triple threat of fatty liver disease, elevated transaminases, and alcohol dependence 3, 4
• The CDC recommends baseline testing to include complete blood count, renal function, hepatic function tests, urine glucose, and urine protein 3, 7

Standard PrEP Components Beyond Hepatic Monitoring

• Quarterly HIV testing using antigen/antibody combination tests is mandatory, as PrEP must never be continued in HIV-positive individuals as dual therapy leads to resistance 5, 6
• Quarterly renal function monitoring and STI screening should be performed as part of comprehensive HIV prevention services 2, 5, 7

Medical Necessity Certification

• The patient meets criteria for PrEP medical necessity based on documented HIV exposure and completed PEP course, with the critical caveat that enhanced hepatic monitoring is required due to the high-risk hepatic profile 3, 4, 5, 7